about
Genetic determinants and potential therapeutic targets for pancreatic adenocarcinomaValidity of self-reported family history of cancer: A systematic literature review on selected cancers.Importance of age of onset in pancreatic cancer kindredsGenetics and pathology of pancreatic cancer.Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.Familial and sporadic pancreatic cancer share the same molecular pathogenesis.Anticipation in familial pancreatic cancer.BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts.The bidirectional interation between pancreatic cancer and diabetes.The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers.Identifying people at a high risk of developing pancreatic cancerPancreatic cancer: why is it so hard to treat?Pancreatic carcinogenesisRisk factors and therapeutic targets in pancreatic cancer.Chemoprevention of pancreatic cancer-one step closer.Familial pancreatic cancer--current knowledge.Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.LCN2 and TIMP1 as Potential Serum Markers for the Early Detection of Familial Pancreatic Cancer.Refinement of screening for familial pancreatic cancer.MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer.German national case collection for familial pancreatic cancer (FaPaCa): ten years experience.Colorectal cancer incidence and trend in UK South Asians: a 20-year study.Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An OverviewClinical and pathologic features of familial pancreatic cancerAdenocarcinoma of the pancreasThe Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer
P2860
Q21129230-A490BBB9-E982-409E-A681-A9B3FE895FBFQ30250104-1F92F5B0-B62D-41C7-BE34-1C2ED0AC136DQ33598358-2EBD89F1-5D82-471E-ADF0-D8C4861B173FQ34589293-600E801E-6422-4BB3-9874-9FEEA76DA192Q34635042-69DE5C51-B8E8-4AED-AE68-CF1D36C3194DQ35171140-D95784DA-BE8D-44AD-84C8-9DCA204C167DQ35761052-38305510-A3E9-462C-8EDE-EC7090424C49Q35909611-7B99B3B9-FBE1-43A1-98A0-4A8303ECB54DQ36402621-1C352A2B-14C3-4C82-AE01-7C138A59B5D2Q36451732-5B6F23DB-DA21-4AE6-882A-C20C1F45A8C0Q36831321-EF43DD69-323C-4704-B27D-8A254BA47E74Q36886497-243006DD-DB0F-4627-9EEC-DC4EE60E5B6BQ37125627-65D11DAB-8858-4FE7-B0DD-F6BCC0ABE363Q37317310-86F61830-105F-4C60-8B04-D7E443499838Q37986594-E8D612DB-22ED-48E9-84A5-2C576C77E727Q38016055-D618B1B8-D298-4ACF-B915-F2E599BF57B0Q39204274-591F1F63-6EC5-44ED-8F62-1FCC53F79CBDQ39382311-68E56D97-1815-4BBC-B158-9C58D6AE5D92Q40736844-E089D598-98CB-400D-8072-B2C12775C757Q41769515-141D89D4-DB52-4D45-AC98-AC1C6A9BA1FBQ43533754-3268374E-529F-47E9-ADA0-E7454FA2EE0DQ44942353-9D6D96AB-8930-47B1-86EC-664378BD0A9BQ46723443-26F7051E-F4AC-4F49-A699-68DF24304B02Q57091632-95F61DEC-6BD1-40E4-B6E4-DBF49C0F57D4Q57422192-33ACA5E8-34EE-4E52-9285-217265DE50D7Q57767566-70268755-277B-49B7-969C-5C59D86F8004Q58708604-AE041100-8CF5-4DA2-A760-724E393E4EB9
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Prevalence of familial pancreatic cancer in Germany.
@en
Prevalence of familial pancreatic cancer in Germany.
@nl
type
label
Prevalence of familial pancreatic cancer in Germany.
@en
Prevalence of familial pancreatic cancer in Germany.
@nl
prefLabel
Prevalence of familial pancreatic cancer in Germany.
@en
Prevalence of familial pancreatic cancer in Germany.
@nl
P2093
P2860
P50
P356
P1476
Prevalence of familial pancreatic cancer in Germany.
@en
P2093
Berthold Gerdes
Cristina Schleicher
Detlef K Bartsch
Esther Endlicher
Harald Rieder
Helmut Messmann
Helmut Schäfer
Helmut Witzigmann
Jan Schmidt
Joachim W Heise
P2860
P304
P356
10.1002/IJC.20210
P577
2004-07-01T00:00:00Z